New pill aims to shed pounds without diabetes
NCT ID NCT07658560
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 2 trial tests whether BGM0504 tablets can help overweight or obese adults without diabetes lose weight. About 200 Chinese participants will take either the drug or a placebo daily for 20 weeks. Researchers will measure changes in body weight, waist size, and blood sugar levels, while also monitoring safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BGM0504 tablets
- What this could lead to
- If successful, this could lead to a new weight-loss medication for people who are overweight or obese but do not have diabetes.
- What could go wrong
- This is an early Phase 2 trial with only 200 participants, so results may not apply to everyone. Side effects are possible, and the drug may not prove more effective than placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University People's Hospital
Beijing, Beijing Municipality, 100044, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?